Ethan G Geier Selected Research

Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar)

1/2019	Genetic variation across RNA metabolism and cell death gene networks is implicated in the semantic variant of primary progressive aphasia.
1/2019	Genome-wide analyses as part of the international FTLD-TDP whole-genome sequencing consortium reveals novel disease risk factors and increases support for immune dysfunction in FTLD.
1/2019	Rare variants in the neuronal ceroid lipofuscinosis gene MFSD8 are candidate risk factors for frontotemporal dementia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ethan G Geier Research Topics

Disease

5	Alzheimer Disease (Alzheimer's Disease) 09/2023 - 09/2016
3	Cognitive Dysfunction 01/2024 - 09/2016
3	Tauopathies 09/2023 - 11/2021
3	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 01/2019 - 01/2019
3	Neoplasms (Cancer) 04/2013 - 07/2010
2	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 11/2023 - 01/2021
2	Atrophy 11/2023 - 01/2018
2	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2023 - 03/2017
1	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 11/2021
1	Muscular Dystrophies (Muscular Dystrophy) 01/2021
1	Parkinson Disease (Parkinson's Disease) 01/2021
1	Inclusion Body Myopathy With Early-Onset Paget Disease And Frontotemporal Dementia 01/2021
1	Frontotemporal Dementia (Semantic Dementia) 01/2019
1	Primary Progressive Aphasia 01/2019
1	Insulin Resistance 01/2018
1	Inflammation (Inflammations) 03/2017
1	Neuroblastoma 04/2011
1	Ototoxicity 07/2010
1	Hearing Loss (Hearing Impairment) 07/2010
1	Atherosclerosis 06/2010

Drug/Important Bio-Agent (IBA)

3	RNA (Ribonucleic Acid)IBA 11/2023 - 01/2019
3	Biomarkers (Surrogate Marker)IBA 01/2018 - 03/2017
1	TESIBA 11/2023
1	DNA Transposable Elements (Element, IS)IBA 11/2023
1	InterferonsIBA 09/2023
1	Small Cytoplasmic RNAIBA 09/2023
1	Antiviral Agents (Antivirals)IBA 09/2023
1	Tuberous Sclerosis Complex 1 ProteinIBA 11/2021
1	Valosin Containing ProteinIBA 01/2021
1	Autophagy-Related ProteinsIBA 01/2019
1	DNA-Binding Proteins (DNA Binding Protein)IBA 01/2019
1	Proteins (Proteins, Gene)FDA Link 01/2019
1	HLA-DQA2 antigenIBA 01/2019
1	DNA (Deoxyribonucleic Acid)IBA 01/2019
1	AndrogensIBA 01/2018
1	Insulin-Like PeptidesIBA 01/2018
1	Insulin (Novolin)FDA Link 01/2018
1	Androgen Receptors (Androgen Receptor)IBA 01/2018
1	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2018
1	Testosterone (Sustanon)FDA Link 01/2018
1	Insulin-Like Growth Factor Binding Protein 2IBA 01/2018
1	ChemokinesIBA 03/2017
1	HLA Antigens (Human Leukocyte Antigens)IBA 03/2017
1	ApolipoproteinsIBA 09/2016
1	Apolipoproteins E (ApoE)IBA 09/2016
1	Thyroid HormonesIBA 04/2013
1	Prescription DrugsIBA 04/2013
1	SodiumIBA 04/2013
1	Large Neutral Amino Acid-Transporter 1IBA 04/2013
1	Amino Acids FDA Link 04/2013
1	Vorinostat FDA Link 04/2011
1	Norepinephrine Plasma Membrane Transport Proteins (Norepinephrine Transporter)IBA 04/2011
1	Histone Deacetylase InhibitorsIBA 04/2011
1	3-Iodobenzylguanidine (Iobenguane)IBA 04/2011
1	Cisplatin (Platino)FDA LinkGeneric 07/2010
1	Copper Transport ProteinsIBA 07/2010
1	Copper Sulfate (Sulfate, Copper)FDA Link 07/2010
1	PlatinumIBA 07/2010
1	CholesterolIBA 06/2010
1	Adenosine Triphosphate (ATP)IBA 06/2010
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 06/2010

Therapy/Procedure

1	Therapeutics 11/2021